Efficacy and safety of 5 mg daily dosing regimens with linagliptin in patients with type 2 diabetes inadequately controlled on metformin

被引：0
|
作者：
Rafeiro, E. [1 ]
Ross, S. A. [2 ]
Meinicke, T. [3 ]
Toorawa, R. [4 ]
Woerle, H. -J. [5 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Burlington, ON, Canada
[2] Univ Calgary, LMC Endocrinol Ctr, Calgary, AB T2N 1N4, Canada
[3] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
[4] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[5] Boehringer Ingelheim KG, D-6507 Ingelheim, Germany
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
831
引用
收藏
页码：S338 / S339
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Controlled Trial
    Cai, Xiao-Ling
    Chen, Ying-Li
    Zhao, Jia-Jun
    Shan, Zhong-Yan
    Qiu, Ming-Cai
    Li, Cheng-Jiang
    Gu, Wei
    Tian, Hao-Ming
    Yang, Hua-Zhang
    Xue, Yao-Ming
    Yang, Jin-Kui
    Hong, Tian-Pei
    Ji, Li-Nong
    [J]. CHINESE MEDICAL JOURNAL, 2015, 128 (10) : 1279 - 1287
  • [32] Efficacy and safety of dapagliflozin in patients with type 2 diabetes on insulin ± metformin regimens
    Yeh, H.
    Katz, A.
    [J]. DIABETOLOGIA, 2015, 58 : S357 - S357
  • [33] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes on Insulin ± Metformin Regimens
    Katz, Arie
    Yeh, Helen
    [J]. DIABETES, 2015, 64 : A317 - A317
  • [34] Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus
    Lu, Chieh-Hsiang
    Wu, Ta-Jen
    Shih, Kuang-Chung
    Ni, Ewan
    Reed, Victoria
    Yu, Maria
    Sheu, Wayne H. -H.
    Chuang, Lee-Ming
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (03) : 144 - 150
  • [35] Efficacy and safety of gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Rhee, E. J.
    Min, K. W.
    Jang, H. C.
    Chung, C. H.
    Nam-Goong, I. S.
    Bae, H. Y.
    Lee, M. K.
    Baik, S. H.
    Shivane, V. K.
    Sosale, A. R.
    Dharmalingam, M.
    Gandhi, P.
    Gupta, S. K.
    Kim, J. A.
    Kim, S. W.
    [J]. DIABETOLOGIA, 2012, 55 : S352 - S352
  • [36] Efficacy and Safety of Gemigliptin Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone
    Rhee, Eun Jung
    Min, Kyung Wan
    Jang, Hak Chul
    Nam-Goong, Il Seong
    Chung, Choon Hee
    Park, Joong Yeol
    Bae, Hak Yeon
    Kim, Doo-Man
    Baik, Sei Hyun
    Lee, Moon-Kyu
    Kim, Byung-Joon
    Chang, Sang Ah
    Ahn, Chul Woo
    Kim, Yong Seong
    Yoon, Kun Ho
    Park, Kyong Soo
    Kim, Hae Jin
    Shivane, Vyankatesh K.
    Sosale, Aravind R.
    Dharmalingam, Mala
    Gandhi, Pramod
    Gupta, Sandeep Kumar
    Pitale, Shailesh
    Agarwal, Pankaj Kumar
    Rais, Nadeem
    Mohan, V.
    Mahesh, Uma
    Kim, Jeong Ae
    Kim, Pan Kyung
    Kim, Sun Woo
    [J]. DIABETES, 2012, 61 : A291 - A291
  • [37] Efficacy and safety of sitagliptin added to ongoing metformin therapy in type 2 diabetes patients who were inadequately controlled on metformin alone
    Meininger, G.
    Charbonnel, B.
    Karasik, A.
    Liu, J.
    Wu, M.
    Meehan, A.
    [J]. DIABETOLOGIA, 2006, 49 : 5 - 6
  • [38] Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia
    Ji, Linong
    Liu, Yanmei
    Miao, Heng
    Xie, Yongli
    Yang, Ming
    Wang, Wei
    Mu, Yuting
    Yan, Ping
    Pan, Sharon
    Lauring, Brett
    Liu, Shu
    Huyck, Susan
    Qiu, Yanping
    Terra, Steven G.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1474 - 1482
  • [39] Safety and efficacy of ertugliflozin compared to glimepiride in patients with type 2 diabetes inadequately controlled on metformin: the VERTIS SU trial
    Hollander, P.
    Liu, J.
    Hill, J.
    Johnson, J.
    Jiang, Z.
    Golm, G.
    Huyck, S.
    Terra, S.
    Mancuso, J. P.
    Engel, S.
    Lauring, B.
    [J]. DIABETOLOGIA, 2017, 60 : S19 - S20
  • [40] EFFICACY AND SAFETY OF ANAGLIPTIN COMPARED WITH SITAGLIPTIN AS AN ADD-ON FOR PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
    Jin, S. -M.
    Park, S. W.
    Yoon, K. -H.
    Lee, M. -K.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S135 - S136
12345